companyapproved

412 results found.

Top Stocks matching your search for "company approved"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

I applaud the company for Learning from their mistakes.

Mar, 21, 2023

$AVXL What a pro active company Biovie. .incredible.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

$TGTX MOST CONVENIENT- 50% faster infusion SAFE... See more

Mar, 11, 2023

Everyone knows that the value of this company is very high.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

But this company has something great

Mar, 16, 2023

But the company actually has never seen before wonderful results.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

I applaud the company for Learning from their mistakes.

Mar, 21, 2023

$AVXL What a pro active company Biovie. .incredible.

Mar, 16, 2023

But this company has something great!

Mar, 16, 2023

But this company has something great

Mar, 16, 2023

But the company actually has never seen before wonderful results.

Feb, 26, 2023

$AVXL this is by far one of the most promising companies that I’ve followed.

Jan, 31, 2023

$AVXL Anavex is ahead of all the other biotechnology companies now. .

Jan, 31, 2023

Good luck to all the long holders of both of these outstanding companies!!!!

Jan, 30, 2023

It’s literally twice as good as the “other company”, without the Brain bleeds.

Jan, 28, 2023

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

$TGTX MOST CONVENIENT- 50% faster infusion SAFEST - Zero Breast Cancer Risk MOST AFFORDABLE - By far If TGTX was a Big Pharma Company, the medical press would be blowing it up with praise.

Mar, 11, 2023

Everyone knows that the value of this company is very high.

Feb, 18, 2023

Getting the current best treatment at the most respectable affordable price is the sweetest deal and gesture that a company can offer.

Feb, 16, 2023

$TGTX is definitely a good company, and worth double what it is right now!

Feb, 3, 2023

Not only do they have the best-in-class treatment, they also have the best-in-class team hired from premier MS companies such as Biogen, Bristol Myers Squibb, Celgene, Genentech, Novartis, and Roche.

Jan, 5, 2023

I am long believe in company

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

But this company has something great

Mar, 16, 2023

But the company actually has never seen before wonderful results.

Mar, 12, 2023

Company doubled in size and reduced cash burn with no risk of dilution.

Mar, 10, 2023

$SAVA I love the potential this company offers us, don't fall for the shorts bs, if we get it rite we are worth 10k not a Penny less

Feb, 6, 2023

$SAVA only see headwinds for this company 😳😳😕😕

Jan, 30, 2023

$SAVA Great company what a shame it's going to 0.

Jan, 13, 2023

Feels good to invest in an innovative, well-run company -- owning some of a limited set of what may soon be in-demand shares isn't too bad either.

Jan, 2, 2023

but SAVA, among other bio companies, remained strong and stable, with a very high market value for a company that does not generate money.